Viewing Study NCT06373757



Ignite Creation Date: 2024-05-06 @ 8:25 PM
Last Modification Date: 2024-10-26 @ 3:27 PM
Study NCT ID: NCT06373757
Status: COMPLETED
Last Update Posted: 2024-04-18
First Post: 2024-04-09

Brief Title: Chitosan Nano-hydroxyapatite Hydrogel in Non-Surgical Treatment of Intrabony Defect
Sponsor: October 6 University
Organization: October 6 University

Study Overview

Official Title: Chitosan Nano-hydroxyapatite Hydrogel in Non-Surgical Treatment of Intrabony Defect Randomized Clinical Trial
Status: COMPLETED
Status Verified Date: 2024-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The aim of this study was to evaluate the clinical effect of Chitosan with nano-hydroxyapatite hydrogel in the treatment of periodontal intrabony defects
Detailed Description: Periodontitis is a chronic inflammation of the periodontium that extends beyond the gingiva and involves the destruction of the connective tissue attachment of the teeth

Treatment modalities of periodontitis includes local drug delivery such as chitosan which is a derivative of the exoskeleton of many arthropods including prawns lobsters and crabs

Chitosan has been used in guided bone regeneration hemostasis of surgical wounds and coating of dental implants in reconstruction of temporomandibular joint disc and guided periodontal tissue regeneration Moreover chitosan has been used for preventing demineralization

HA also called hydroxylapatite is a naturally occurring mineral form of calcium apatite with the formula Ca5PO43OH The OH- ion can be replaced by fluoride and carbonate producing fluorapatite or chlorapatite It crystallizes in the hexagonal crystal system

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None